Backing what comes next.

Koodos is a modern, FCA-regulated venture investment company backing ambitious founders with capital, structure, and long-term support.

Follow us -

A modern venture platform for founders and investors building the future.

For Investors:

Access to curated venture opportunities. Clear structure and regulatory oversight. A modern alternative to traditional private markets.

For Founders:

Capital without unnecessary constraint. Strategic and governance support. A network of peers building at a similar level.

How we're different.

Koodos combines institutional discipline with a modern, human approach.

We’re not a traditional venture capital fund. We’re not a loose angel network. We’re not a hype-driven community.

We provide structured access to high-quality venture opportunities, with FCA-regulated oversight and a focus on long-term value – not short-term noise.

We apply private-equity discipline to early-stage venture investing — combining governance, downside protection, and active value creation with the upside of early growth.

Built on trust.

Venture investing has traditionally been closed, opaque, and intimidating. Koodos exists to change that. We’re FCA-regulated, which means clear structure, transparent processes, and regulatory oversight. We’re honest about risk, clear about timelines, and focused on building meaningful companies. This isn’t about lowering standards. It’s about broadening access while maintaining discipline.

Structure. Support. Long-term thinking.

We back founders who are building companies that matter. We support investors who understand that venture is a long-term game. And we create a place where both can engage with confidence. Every investment receives proper governance support. Every founder gets genuine partnership. Every decision is made with long-term value in mind.
Latest News

Latest insights

Denmark’s Cancer Transformation and Why It Matters for 2cureX

Exploring a recent article from the BBC underscoring the urgency of accelerating innovation in cancer care and the scale of opportunity.

From 360,000 Lawyer Hours to Seconds: How JP Morgan's AI Revolution Is Rewriting Finance

The time-save translates to real money ($144M+ annually) and strategic advantage, not just efficiency gains.

Precision Oncology for All: 2cureX's Mission to Democratise Personalised Cancer Care

2cureX is making personalised cancer treatment accessible to patients worldwide, not just those at elite medical centers.

Investors
Founders
About
Contact

Risk Warning.

Capital at risk. Investments in early-stage companies are high-risk and illiquid. You may lose all capital invested. Only invest what you can afford to lose. Past performance is notindicative of future results.

Venture investments typically require a 7-10 year time horizon and may result in total loss of capital. Diversification is recommended. Seek independent financial advice if unsure about suitability.

Don’t invest unless you're prepared to lose all your money. These are high-risk investments and you are unlikely to be protected if something goes wrong.

Learn More